Organ Preservation Solution Market Revenue to Cross $ 399.49 Billion, with 7.8% CAGR during (2023-2028) – The Insight Partners

The Insight Partners published latest research report on “Organ Preservation Solution Market Size Report, Share, Trends & Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, Organ Type, and End User”, the global market share is projected to reach USD 399,497.49 million by 2028 from USD 255,917.42 million in 2022. The market is estimated to grow with a CAGR of 7.8% from 2023 to 2028.

Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100001100

Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body. Organ conservation plans are implemented to save and maintain the value of organs for future applications such as transplantation and research. The development of organ preservation technologies is expected to be fuelled by growing interest in organ transplantation procedures across the globe. Similarly, developing mechanically propelled techniques for saving organs support the market growth for organ preservation solutions.

Global Organ Preservation Solution Market: Competitive Landscape and Key Developments

Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST CENTURY MEDICINE, Shanghai Genext Pharmaceutical Technology, and Bridge, Perfusion Solutions, Inc., Lifeline Scientific, to Life Ltd are a few key companies operating in the global organ preservation solution market. These players are focusing on expanding and diversifying their market presence and acquiring a novel customer base, thereby tapping prevailing business opportunities in the market.

Many market players are launching innovative products with advanced features in the global organ preservation solution market. Also, companies have announced acquisitions of players to enhance their product portfolio.

In August 2022, Paragonix Technologies, Inc. announced a significant milestone of preserving over 2,000 donor organs while also providing transplant hospitals with Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these technologies employs first-of-their-kind preservation methods and has proven to improve conventional ice and cooler practices significantly.

In June 2022, Paragonix Technologies, Inc. expanded the adoption of its LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in Boston, Massachusetts. Since the commercial introduction of the LIVERguard system in January 2022, the advanced donor organ preservation system has been utilized at 8 transplant centers in the US, including UF Health Shands, one of the largest liver transplant centers in the world. Paragonix has also been partnering with numerous Organ Procurement Organizations to provide more access to this unique hypothermic preservation technology.

In April 2022, TransMedics Group, Inc. received premarket US Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD). The OCS Heart System is now approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts.

Directly Purchase Premium Copy of Organ Preservation Solution Market Growth Report (2023-2028) at: https://www.theinsightpartners.com/buy/TIPHE100001100

Global Organ Preservation Solution Market Share Report, Segmentations, Regional & Country Scope:

Browse key market insights spread across 211 pages with 113 list of tables & 80 list of figures from the report, “Organ Preservation Solution Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/organ-preservation-market

An increase in chronic kidney diseases and prevalence of the geriatric population in the US are a few factors expected to accelerate the development of the organ preservation solutions market. For instance, according to the National Chronic Kidney Disease fact sheet, in 2021, approximately 37 million people suffer from chronic kidney diseases in the US. Furthermore, according to the American Kidney Fund, Inc, ~810,000 Americans have kidney failure, out of which 570,000 patients are undergoing dialysis, and 240,000 have undergone kidney transplantation. In addition, according to CDC, Chronic Kidney Disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%) in 2021. Further, with the increasing prevalence of CKD in the US, CKD-related health problems deteriorate over time, leading to increased chances of heart disease and stroke. All these factors are likely to increase the number of kidney transplantations in the coming years. Moreover, rising FDA approvals and presence of major players in the region are a few factors boosting the market. For instance, in April 2022, TransMedics Group, Inc. received premarket US Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD). The OCS Heart System is now approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts. Thus, the rising need for organ transplantation is among the key factors driving the organ preservation solutions market.

Global Organ Preservation Solution Market: Segmental Overview

The global organ preservation solution market is segmented on the basis of type, application, organ type, and end user. Based on type, the market is segmented into University of Wisconsin solution (UW), custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment held the largest market share in 2022, and the hypothermosol segment is anticipated to register the highest CAGR during the forecast period. Based on application, the global organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. By organ type, the market is classified into kidney, liver, lung, heart, and others. Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics.

Global Organ Preservation Solution Market Growth Drivers - Rising Need for Organ Transplantation:

Organ transplantation is a surgical procedure used when a patient’s organ no longer functions properly. Organ transplantation is mostly done for the heart, liver, and kidney. However, the rising prevalence of chronic diseases necessitates organ transplantation for organs such as lungs, pancreas, cornea, and vascular tissues. Organ transplantation is regarded as one of the most significant advances in modern medicine.

Speak To Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001100

Chronic diseases cause damage to the functions of the heart, lungs, liver, kidney, and other organs; the prevalence of chronic diseases leads to an increase in the number of organ transplants. Moreover, excessive alcohol consumption leads to liver cirrhosis and ultimately needs a liver transplant, and a poor diet contributes to the development of renal and hepatic illnesses, which can lead to organ failure. This is another factor contributing to the increase in organ transplantation, which is driving the organ preservation solutions market. Transplantation surgeries are becoming more common across the globe. For instance, in Spain, the Organizacion Nacional de Transplantes (ONT) manages the organ donation program that increased the number of donations from 14.3 per million population in 1980 to 49 deceased donors per million population in 2019. Furthermore, as per the ONT, there was a 40% increase in donors from 2016 to 2021. By adopting a “50-22” directive in Spain for organ donation, the goal was to reach 50 donors per million population by 2022.

The public-private partnership, in collaboration with transplant coordinators, has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries experienced an increase in the number of organ transplant surgeries. Developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific and progressing in terms of providing better and more advanced medical treatments.

According to the U.S. Department of Health and Human Services, more than 1 in 7, that is 15% of US adults or approximately 37 million people, had chronic kidney disease in 2021. As a result, the rising incidence of chronic kidney diseases is likely to increase the demand for kidney transplantation in the coming years, which boosts the need for solutions to keep the organs in a healthy condition.

Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):

Organ Transplantation Market Forecast to 2028 - Covid-19 Impact and Global Analysis

Medical Perfusion Technology Market Forecast to 2027 - COVID-19 Impact and Global Analysis

Pediatric Perfusion System Market Forecast to 2028 - Covid-19 Impact and Global Analysis

Perfusion Systems Market to 2027- Global Analysis and Forecasts

Hemoperfusion Market Forecast to 2028 - Covid-19 Impact and Global Analysis

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Press Release: https://www.theinsightpartners.com/pr/organ-preservation-market